Rhythm Pharmaceuticals, Inc. (RYTM)
106.76
-5.79
(-5.14%)
USD |
NASDAQ |
Dec 30, 16:00
106.01
-0.75
(-0.70%)
After-Hours: 20:00
Rhythm Pharmaceuticals Profit Margin (Quarterly): -103.1% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.72% |
| Gilead Sciences, Inc. | 39.21% |
| Johnson & Johnson | 21.47% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Geron Corp. | -39.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -509.3% |
| Return on Assets | -47.53% |
| Return on Invested Capital | -65.09% |
| Gross Profit Margin (Quarterly) | 89.08% |
| Operating Margin (Quarterly) | -102.6% |
| Return on Net Operating Assets | -363.7% |